HomeINTI • OTCMKTS
add
Inhibitor Therapeutics Inc
Previous close
$0.050
Year range
$0.034 - $0.095
Market cap
8.63M USD
Avg Volume
12.86K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 695.77K | 18.91% |
Net income | -659.94K | -31.54% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.74M | -47.34% |
Total assets | 3.91M | -45.53% |
Total liabilities | 3.19M | 5.16% |
Total equity | 715.64K | — |
Shares outstanding | 172.57M | — |
Price to book | ∞ | — |
Return on assets | -41.35% | — |
Return on capital | -155.99% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -659.94K | -31.54% |
Cash from operations | -583.99K | -0.16% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -583.99K | -0.16% |
Free cash flow | -382.53K | 14.66% |
About
Founded
1992
Headquarters
Website
Employees
6
